Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head and Neck Cancer—Pilot Results from RTOG 0522

PURPOSE: To evaluate candidate FDG-PET/CT imaging biomarkers for head and neck chemoradiotherapy outcomes in the cooperative group trial setting. METHODS: RTOG 0522 patients consenting to a secondary FDG-PET/CT sub-study were serially imaged at baseline and 8 weeks following radiation. Maximum stand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Schwartz, David L., Harris, Jonathan, Yao, Min, Rosenthal, David I., Opanowski, Adam, Levering, Anthony, (R)(CT)(MR), RT, Ang, K. Kian, Trotti, Andy M., Garden, Adam S., Jones, Christopher U., Harari, Paul, Foote, Robert, Holland, John, Zhang, Qiang, Le, Quynh-Thu
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672942/
https://ncbi.nlm.nih.gov/pubmed/25752384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2014.12.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados